Skip to main navigation
Skip to search
Skip to main content
University of Kentucky Home
LOGIN & Help
Link opens in a new tab
English
Español
Search content at University of Kentucky
Home
Research units
Researchers
Projects & Grants
Research Output
Facilities & Equipment
Honors & Awards
Activities
Systemic Delivery of miR-29 for Basal-like Breast Cancer Treatment
Xu, Ren
(PI)
Chen, Li
(CoI)
Shu, Dan
(Former CoPI)
Markey Cancer Center / Cancer Research Priority Initiative
Overview
Fingerprint
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Pharmacology, Toxicology and Pharmaceutical Science
Basal Like Breast Cancer
100%
microRNA 29
100%
microRNA 29b
43%
Nanoparticle
43%
Neoplasm
43%
Breast Tumor
18%
microRNA
18%
Aptamer
18%
Tumor Suppressor Protein
18%
Cancer Growth
12%
Malignant Neoplasm
6%
Cell Surface Marker
6%
Endocrine Therapy
6%
Cancer Recurrence
6%
Estrogen Receptor
6%
Cell Marker
6%
Epidermal Growth Factor Receptor 2
6%
Epidermal Growth Factor Receptor
6%
Progesterone Receptor
6%
Diseases
6%
Immunology and Microbiology
Ribonucleic Acid
100%
Cancer Stem Cell
87%
Cancer Tissue
25%
Breast Cancer Cell Line
25%
Cell Marker
12%
Cell Surface Marker
12%
Cancer Cell
12%
CD44
12%
Target Cell
12%